Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Felbatol
Synonyms :
Class :
Anticonvulsants; Antiepileptic agents
Dosage forms & Strengths:
Adult:
Tablet:
400 mg
600 mg
Oral suspension:
600 mg/5 ml
1200 mg orally each day divided at an interval of 6 hours
Increase the dose to 25 mg/day every 5-7 days if required
1200 mg orally each day divided at an interval of 6 hours
Increase the dose to 25 mg/day every 5-7 days if required
felbamate: they may diminish the serum concentration of hormonal contraceptives
felbamate: they may diminish the serum concentration of hormonal contraceptives
felbamate: they may diminish the serum concentration of hormonal contraceptives
felbamate: they may diminish the serum concentration of hormonal contraceptives
may diminish the serum concentration of phenobarbital
spironolactone and hydrochlorothiazide
may enhance the toxic effects of the other by pharmacodynamic synergism
may enhance the toxic effects of the other by pharmacodynamic synergism
may enhance the toxic effects of the other by pharmacodynamic synergism
may enhance the toxic effects of the other by pharmacodynamic synergism
may enhance the toxic effects of the other by pharmacodynamic synergism
it increases the toxicity of norepinephrine reuptake inhibitors
it increases the toxicity of norepinephrine reuptake inhibitors
it increases the toxicity of norepinephrine reuptake inhibitors
it increases the toxicity of norepinephrine reuptake inhibitors
it increases the toxicity of norepinephrine reuptake inhibitors
CYP3A strong enhancers of the small intestine may reduce the bioavailability of felbamate
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
may increase the adverse or toxic effect of anti-psychotic agents
When felbamate is used together with bromisoval, the risk or seriousness of CNS depression is enhanced
When felbamate is used together with medazepam, the risk or seriousness of CNS depression is enhanced
The potential for CNS depression may enhanced when felbamate is used together with fencamfamin
When felbamate is used together with niaprazine, the risk or seriousness of CNS depression is enhanced
When felbamate is used together with levosulpiride, the risk or seriousness of CNS depression is enhanced
When dexrabeprazole and felbamate is used together, this leads to reduction in the dexrabeprazole’s metabolism
When acetohexamide is used together with felbamate, this lead to reduction in acetohexamide’s metabolism
When felbamate is used together with melitracen, this leads to enhanced risk or seriousness of CNS depression
when both drugs are combined, there may be an increased metabolism of paclitaxel
the effect of felbamate is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
When felbamate is used together with lomitapide, this leads to an enhancement in lomitapide’s metabolism
it decreases the concentration of hormonal contraceptives in serum
>10%:
Nausea (34.2%)
Vomiting (16.7%)
Constipation (11.4%)
Dyspepsia (12.3%)
Anorexia (19.3%)
Dyspepsia (
Anorexia (55%)
Somnolence (48%)
URI (46-50%)
Vomiting (39%)
Nervousness (16-20%)
Insomnia (16.1%)
Purpura (11-15%)
Fever (22.6%)
Constipation
1-10%:
Acne
Anxiety
Constipation
Diarrhea
Diplopia
Dyspepsia
Face edema
Fatigue
Headache
Insomnia
Intramenstrual bleeding
Otitis media
Rash
Urinary tract infection
Vomiting
<1%:
Atrial arrhythmia
Bradycardia
Hypotension
Thrombophlebitis
Cerebral edema
Coma
Alopecia
Hepatic failure
Rigors
Rhabdomyolysis
Felbamate is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.
Pregnancy consideration:
Category C.
Breastfeeding warnings:
Avoid taking the medication during breastfeeding
Pregnancy category:
Patient information leaflet
Generic Name: felbamate
Pronounced: ami-tryp-ti-line
Why do we use felbamate?
Felbamate treats seizures.